跳至主要内容
临床试验/IRCT201206101808N4
IRCT201206101808N4已完成未知

Comparison of continuous infusion of sodium valporate and midazolam in children status epilepticus

Research Center of Mazandaran University of Medical Sciences and Health Services0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 months 至 14 years(—)
性别
All

入选标准

  • Minimum age 3 month and maximum 14 years old ; Absence of renal or hepatic disfunction, shock, atrial or ventricular block ; No drug history of valproate or midazolam therapy in control of status epilepticus ; Normal range of CBC, BS,Ca, Na, K, BUN, Cr, SGOT, SGPT at beginning of treatment ; No control of status epilepticus with first line drugs such as diazepam, Phenytoin and Phenobarbital.
  • exclusion criteria: all children with acute or chronic liver disease ; all children with metabolic disease ; seizure in children with trauma ; all children with coagulation disfunction

排除标准

  • 未提供

研究者

发起方
Research Center of Mazandaran University of Medical Sciences and Health Services

相似试验